100% Quality Guarantee
PhD-Level Technical Support
Key Features

Recombinant BID Monoclonal Antibody (AGEL5367)

SKU AGEL5367
Product Type Antibody
Reactivity Human
Applications WB, IHC, ICC/IF, FC, IP
Host Species Rabbit
Clonality Monoclonal
Clone C310048
Conjugate Unconjugated
$540 - $738

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Recombinant BID Monoclonal Antibody

The Recombinant BID Monoclonal Antibody is a recombinant rabbit monoclonal antibody (clone C310048) against BID. This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2, and thus regulate apoptosis. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Produced by recombinant technology in Rabbit hosts and purified by Protein A affinity chromatography, this Rabbit IgG antibody is reactive against Human samples.

This antibody is suitable for WB, IHC, ICC/IF, FC and IP applications. It has been validated by WB analysis of HCT116, Jurkat, 293T, A431, A549, HepG2, IHC analysis of Human colon cancer and IF analysis of HeLa.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose